/Companies

Gemstone BioTherapeutics

Baltimore, US · Founded 2013 · Maryland LLC

Find your way into Gemstone BioTherapeutics

Sign up to see every warm intro you have to Gemstone BioTherapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Gemstone BioTherapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

GDGeorge Davis
George DavisCEO2013–2017George Davis is a Chief Executive Officer at Gemstone BioTherapeutics with prior experience in venture capital and private equity, and expertise in business development across technology and biotechnology sectors.
SG
Sharon GerechtNamed on SEC filing

Board

DO
David OrosBoard director
XH
Xin HuangBoard director

Reported raises · per SEC filings

Form D private placements

$2.3M disclosed across 2 rounds · 2015–2016

▶$700KraisedOct 2016 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George DavisExecutive Officer, Director, Promoter
  • David OrosDirector, Promoter
  • GEOFF MACKAYDirector
  • Xin HuangDirector
Offering amount
$3.5M
Amount sold
$700K
Minimum investment
$100K
First sale
Oct 2016
Incorporated
Limited Liability Company, Maryland, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedJun 2015 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sharon GerechtDirector
  • George DavisExecutive Officer, Director, Promoter
  • Xin HuangDirector
  • David OrosDirector, Promoter
Offering amount
$1.6M
Amount sold
$1.6M
Minimum investment
$100K
First sale
Jun 2015
Incorporated
Limited Liability Company, Maryland, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Gemstone BioTherapeutics raised?
Gemstone BioTherapeutics has disclosed $2.3M raised across 2 rounds.
Where is Gemstone BioTherapeutics headquartered?
Gemstone BioTherapeutics is headquartered in Baltimore, US.